Editorial: ustekinumab and Crohn's disease-what can we learn from long-term extension studies?
- PMID: 29998500
- DOI: 10.1111/apt.14844
Editorial: ustekinumab and Crohn's disease-what can we learn from long-term extension studies?
Comment on
-
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.Aliment Pharmacol Ther. 2018 Jul;48(1):65-77. doi: 10.1111/apt.14794. Epub 2018 May 24. Aliment Pharmacol Ther. 2018. PMID: 29797519 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources